The study examined seven drugs: Finming-Topimidomy, Natutone-Amphoneone, Olis, Two-meta, SGLT2 inhibitors, Pulanglin peptide, GLP-1 receptor agonists (Smeglu Peptide. Liculugin, Essean peptide).
A total of 14,605 ​​studies were included in this study, and 132 studies were finally eligible for inclusion, involving a total of 48,209 subjects.

The results showed that:
Compared with simply changing lifestyle, all drugs can reduce weight.
Among them, the weight loss effect of natesterone-azithromycin and GLP-1 drugs is significantly better than other types of drugs;
Without the occurrence of adverse reactions similar to other drugs, Smegtugptide showed a stronger weight loss effect than other drugs. Whether it is a proportion of more than 5% or the overall weight loss effect, it is far ahead.